Table 1.
Baseline Characteristics of patients with stable angina.
Table 2.
Medication use of patients with stable angina at inclusion.
Figure 1.
Comparison of levels of cytokines for FFR-positive and FFR-negative patients and healthy controls.
*Comparison by Kruskal-Wallis test.** Between subgroup differences compared with Mann Whitney U test.
Figure 2.
Expression levels of TLR2 and TLR4 on monocytes (A) and granulocytes (B) FFR-positive and FFR-negative patients and healthy control subjects.
*Comparison by Kruskal-Wallis test for all groups.** Between subgroups with Mann Whitney U test. TLR = toll-like receptor.
Figure 3.
Expression levels of CD11b, CD62L and CD14 on monocytes (A) and CD11b and CD62L on granulocytes (B) in FFR-negative patients, FFR-positive and healthy control subjects.
*Comparison by Kruskal-Wallis test for all groups.** Between subgroups with Mann Whitney U test.
Figure 4.
Concentrations of cytokines and surface markers on monocytes and granulocytes according to FSS tertiles and FFR-negative patients.
Concentrations of cytokines (A) and surface markers on monocytes (B) and granulocytes (C) according to FSS tertiles (of FFR-positive patients) and FFR-negative patients. Comparison of all subgroups was performed with the Jonckheere-Terpstra test. FSS = functional syntax score.